共 73 条
[1]
Lisnevskaia L(2014)Systemic lupus erythematosus Lancet 384 1878-1888
[2]
Murphy G(2016)The frequency and outcome of lupus nephritis: results from an international inception cohort study Rheumatology (Oxford) 55 252-262
[3]
Isenberg D(2017)A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS) Ann Rheum Dis 76 554-561
[4]
Hanly JG(2011)Infections in the lupus patient: perspectives on prevention Curr Opin Rheumatol 23 358-365
[5]
O'Keeffe AG(2011)Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006 Arthritis Rheum 63 1681-1688
[6]
Su L(2012)Survival analysis and causes of mortality in patients with lupus nephritis Nephrol Dial Transplant 27 3248-3254
[7]
van Vollenhoven R(2018)Lupus nephritis: current treatment paradigm and unmet needs Rev Recent Clin Trials 13 105-113
[8]
Voskuyl A(2019)Refractory lupus nephritis: when, why and how to treat Autoimmun Rev 18 510-518
[9]
Bertsias G(2020)2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis Ann Rheum Dis 79 713-723
[10]
Barber C(2003)Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator Arthritis Rheum 48 3253-3265